Click on the link to download the EAACl Beijing Allergy School 2026_Sponsorship prospectus

EAACI Beijing Allergy School 2026 & PUMCH Allergy Symposium Sponsors:

Allergy Therapeutics

Allergy Therapeutics is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Driving convenience; our short-course treatments make life easier. Our adjuvant technologies not only advance the results of allergy immunotherapy but also drive beneficial immune responses in cancer and infectious disease. Our operations deliver growth and transforms the way we think about immunology.

Reacta Healthcare

Reacta Healthcare, established in 2013, operates from a pharmaceutical manufacturing facility in Deeside, North Wales. It is licenced to manufacture challenge meals for use in clinical trials. These challenge meals are currently used to diagnose and monitor food allergy in numerous worldwide therapeutic trials. Patents for the challenge meals have been granted in a number of countries.

Reacta Healthcare is developing its in-house analytical capability and has plans in place for expansion into niche areas of food allergen development and manufacture. This will include all aspects from sourcing through to manufacture of end product.